US 9376480
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
granted A61KA61K38/00A61K38/47
Quick answer
US patent 9376480 (Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/00, A61K38/47, A61P, A61P3/00